| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 27-Dec-08 | | Total Revenue | 107,593 | 98,479 | 105,422 | 124,388 | | Cost of Revenue | 70,093 | 64,865 | 65,815 | 73,999 | | | Gross Profit | 37,500 | 33,614 | 39,607 | 50,389 | | | Operating Expenses | | Research Development | 15,500 | 15,529 | 15,610 | 14,778 | | Selling General and Administrative | 27,285 | 29,223 | 27,962 | 23,628 | | Non Recurring |
-
|
-
|
-
| 19,286 | | Others | 1,722 | 1,907 | 1,894 | 1,943 | | | | Total Operating Expenses |
-
|
-
|
-
| 59,635 | | | | Operating Income or Loss | (7,007) | (13,045) | (5,859) | (9,246) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,865 | 3,386 | (1,568) | (4,153) | | Earnings Before Interest And Taxes | (5,142) | (9,659) | (7,427) | (13,399) | | Interest Expense | 62 | 57 | 32 | 77 | | Income Before Tax | (5,204) | (9,716) | (7,459) | (13,476) | | Income Tax Expense | (709) | (2,701) | 1,671 | 1,203 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,495) | (7,015) | (9,130) | (14,679) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,495) | (7,015) | (9,130) | (14,679) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,495) | ($7,015) | ($9,130) | ($14,679) |
|
0.02% Nasdaq 
Income Statement
